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 Nanoparticles (NPs) are ideal drug carriers because of their small, biocompatible size and 
high surface to volume ratio. Therapeutic, targeting, and diagnostic moieties can be attached to 
the NP simultaneously to create a novel ―multifunctional‖ therapeutic agent. Herein, efforts 
toward the synthesis of poly(ethyleneglycol) (PEG) and silica-coated iron oxide (FexOy) NPs that 
can be functionalized with anti-tumor and molecular targeting agents are described. FexOy is a 
superparamagnetic T2 magnetic resonance imaging (MRI) contrast agent. MRI can be used as a 
diagnostic tool to track FexOy NPs in vivo. PEG and silica have uniform surface chemistry that is 
ideal for 1) affording biocompatibility, 2) alleviating aggregation of FexOy NPs, and 3) serving as 
a scaffold for future functionalization of the nanovehicle. A variety of synthetic methods were 
investigated to deposit a thin (1-10 nm) layer of silica, PEG, or a mixed silica-PEG interface on 
commercially-synthesized (Ferrotec EMG 304 ®)10 nm superparamagnetic iron oxide (SPIO) 
cores. Surface-modified products were characterized with FT-IR spectroscopy, transmission 
electron microscopy (TEM), dynamic light scattering (DLS), and MRI relaxivity studies. FT-IR 
and TEM confirmed successful PEGylation of SPIOs with a PEG-silane species. Aggregation 
and polydispersity were key issues in the silica-modification syntheses. The smallest (15-20 nm 
overall particle size, 1-3 nm silica layer), most monodisperse silica-coated SPIOs were produced 
using a microemulsion synthesis with a short (1 hr) reaction time. MRI relaxivity studies of bare 
and surface-modified SPIOs were able to quantify the T2-MRI contrast effect of NPs. Surface-
modified SPIOs were quantified to have less contrast than bare SPIOs, which appeared to result 
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1 Introduction  
 
At the turn of the twentieth century, Nobel Prize Laureate Dr. Paul Erlich popularized the 
idea of a ―magic bullet‖ for treating disease1. If a compound could be synthesized or found to 
selectively target diseased cells in the body, Erlich reasoned, a toxin could be delivered with this 
compound to selectively destroy those - and only those - diseased cells. A century later, we are 
making effort toward Erlich‘s concept of a ―magic bullet‖ therapy. Specifically, the goal of this 
project is to build a multifunctional, targeted therapy for pancreatic cancer, an aggressive form of 
cancer with an average survival rate of less than one year and no effective therapies
2
. 
Nanoparticles (NPs) are ideal platforms for building a multifunctional therapeutic agent 
because their small size enables cell entry for molecular targeting and there are well-studied 
synthetic pathways to conjugate anti-tumor moieties onto their surface
3
. The aim of this study is 
to build on previous work
4,5
 to optimize the synthesis of a NP with a superparamagnetic iron-
oxide (SPIO/FexOy) core, which will be conjugated to a monoclonal antibody (mAb) and boron-
loaded polypeptide, poly D-glutamate: D-lysine (poly-GL), to target (via specific antigen-
antibody interactions) and kill (via boron neutron capture therapy
6
) pancreatic tumor cells, 
respectively (Figure 1). The SPIO core is important because the nanoparticle can serve as a 
magnetic resonance imaging (MRI) contrast agent, making it a valuable diagnostic tool in 








. Au NP with iron-oxide core functionalized 








 have already investigated the direct coating of SPIOs with a thin 
layer of gold (Au), which provides thiol (-SH) linkers for conjugating the mAb and Poly-GL 
(Figure 1). Both reported limited success, citing presence of uncoated SPIO cores as the main 
concern. The focus of this study is to pursue alternative synthetic routes to attain a protective 
coating of the SPIO cores for future functionalization. First, in continuation with investigations 
by Yayla, a synthesis for silica-coated SPIO cores is being investigated. With versatile silanol (-
Si-OH) attachment sites on the surface, silica can act as a precursor for a layer of gold
7
 and/or 
provide a scaffold for direct conjugation with ligands
8
. Second, poly(ethyleneglycol) (PEG) is 
also being investigated as a scaffold and protective layer. Not only is PEG a well-known agent 
for improving blood half-life due to its hydrophilicity
9
, but its terminal hydroxyl groups can also 
be conjugated with therapeutic and targeting groups
10
. Figure 2 is an overview of both synthetic 










An additional goal of this study is to quantitatively characterize and monitor if/how MRI contrast 
of SPIO cores changes upon synthetic modification because size and surface chemistry is likely 
Figure 2. 10 nm SPIO cores are (A) coated with a silane-PEG species and 
(B) coated with silicon dioxide (silica) using tetraethylorthosilicate (TEOS), 
a silica-precursor.   
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to influence efficacy of the contrast agent (section 1.2.2). A theoretical and literature overview of 
MRI and molecular-targeting SPIO contrast agents is presented in the following sections.  
1.1 MRI Theory11,12,13  
 
 MRI relies on principles of nuclear magnetic resonance (NMR) to produce high-contrast 
and high-resolution images of soft tissue inside the body non-invasively, making it a powerful 
diagnostic technique. In this overview, the principles of NMR relevant to MRI will be presented 
followed by a discussion about how the NMR signal is collected and spatially encoded to create 
a MR image.  
1.1.1 NMR 
 
 Nuclei with an odd number of protons, neutrons, or both are considered ―NMR active‖ 
because they have a non-zero value of an intrinsic quantum mechanical property called spin, 
which gives rise to non-degenerate spin energy states in the presence of a magnetic field. 
Notably, these spin states are quantized and the number of states is given by: 
                                (1) 
where S is the spin angular momentum quantum number. Nearly every element on the periodic 
table has some NMR-active isotope (i.e. S ≠ 0), but often the isotopic abundance is not high 
enough to be detected. 
1
H, which has S = ½, is used in MR imaging not only because of its 
natural isotopic abundance (99.9%), but also because of its molecular abundance in water (H2O), 
which comprises about 60% of the human body
11
. According to equation (1), a hydrogen proton 
has two spin states (designated as – ½ and + ½) that lose their degeneracy in a magnetic field. 
The frequency associated with the quantized energy difference between the two states is called 
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the Larmor frequency (   and it varies with the strength of the external magnetic field (B0) and 
the gyromagnetic ratio ( ), which is a fixed proportionality constant specific to each nucleus[1]: 
       (2) 
A NMR signal is produced from the interaction of electromagnetic energy at the appropriate 
Larmor frequency (fortunately in the non-ionizing radiofrequency (RF) range) with nuclei in 
each spin state. In order to provide a more tangible explanation of this phenomenon, it is helpful 
to invoke the classical (Newtonian) treatment of spin for hydrogen nuclei.  
In the classical model, hydrogen nuclei may be assumed to be ―spinning‖ about their own 
axes, each producing a magnetic dipole moment. In the absence of B0, magnetic dipole moments 
point in random directions and cancel each other out, producing zero bulk magnetization. On the 
other hand, in the presence of B0, the magnetic dipole moments of hydrogen nuclei align with or 
against B0 – the two quantized spin states predicted with the quantum mechanical treatment of 








Nuclei that have their magnetic dipole moments aligned with B0 are in the lower energy spin 
state and those with their magnetic dipole moments against B0 are in the higher energy spin state. 
                                                          
[1]
 For hydrogen, γ = 42.6 MHz/Tesla. NMR spectrometers of different magnetic field strengths are often designated 




. In the absence of B0, zero net magnetization 




Due to a slight excess of nuclei in the lower spin state at equilibrium
[2]
, there is a longitudinal 
bulk magnetization vector (M0) in the direction of B0 that is a vector sum of individual nuclear 







To produce and detect a NMR signal, however, requires that the longitudinal magnetization be 
perturbed from its equilibrium state along the B0 axis into a transverse plane where there is a RF 
receiver coil that can monitor the precession of bulk magnetization as it returns to equilibrium. 
This is achieved by applying a RF pulse perpendicular to the longitudinal magnetization in 






                                                          
[2]
 The relative abundance of nuclei in each spin state at equilibrium can be derived using the Boltzmann 
Distribution: 
      
      
   
  
   
where Nupper and Nlower correspond to the number of nuclei in the higher and lower energy spin states, respectively; 
ΔE is the difference in energy between the spin states; k is the Boltzmann constant; and T is the temperature. 
Because ΔE is small, the populations of nuclei in each spin state are nearly identical with a slight excess (~ ten in a 
million) of nuclei in the lower energy spin state. Because the NMR signal arises from the RF energy absorbed and 
emitted by nuclei that are transitioning between the two spin states, the ten in a million excess of spins is critical to 
produce a non-zero signal. The ten in a million excess of spins also explains the low sensitivity of NMR/MRI. 
Figure 4
13
. Precession of nuclear 
spins at Larmor frequency around 
B0 axis produces net longitudinal 
magnetization (M0). Because the 
precession is out of phase, there is 
no net magnetization in the 
transverse (x-y) plane.  
Figure 5
11
. Application of a RF 
pulse perpendicular to M0 at its 
Larmor frequency ―flips‖ M0 
into the transverse (x-y) plane.  
Rana 10 
 
After the RF pulse, bulk magnetization precessing out of phase around B0 also begins to precess 
in phase around the smaller magnetic field associated with the RF pulse, resulting in a spiral 
motion of the longitudinal magnetization into the transverse plane. In a rotating frame of 
reference (Figure 5), the longitudinal magnetization ―flips‖ into the transverse plane. How far it 
flips away from the B0 axis (i.e. the flip angle θ in Figure 5) is a function of the strength and the 
duration of the RF pulse; a 90º RF pulse flips all longitudinal magnetization into the transverse 
plane.  
After completion of the RF pulse, transverse magnetization decays through T1 and T2 
relaxation processes (discussed below) to re-establish equilibrium along the B0 axis. As 
relaxation takes place, the magnetic field oscillating at the Larmor frequency in the transverse 
plane induces current in a RF receiver coil, which produces a decaying sinusoidal signal called a 
free induction decay (FID). FIDs, as discussed in 1.1.3, are spatially encoded and Fourier 
transformed to produce an MR image.   
1.1.2 T1 and T2 Relaxation 
 
A 90º RF pulse tips bulk magnetization into the transverse plane where it precesses in 
phase. What happens after the RF pulse is turned off? Thermodynamically, a system wants to re-
establish equilibrium and return to its lowest energy state. Two separate, simultaneous processes 
occur after application of the RF pulse to return the spin state system to equilibrium: 
1. Nuclei return to their lowest spin energy state  
2. Nuclear spins precessing in phase get out of phase with each other 
In the classical vector model this corresponds, respectively, to: 
1. Recovery of the longitudinal component of bulk magnetization along the B0 axis  
2. Loss, or dephasing, of the transverse component of bulk magnetization  
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T1 and T2 relaxation are the terms used to describe the recovery of longitudinal magnetization 







Mathematically, T1 and T2 are time constants in exponential functions (the Bloch equations) (3, 
4) that characterize the rate of the two independent processes: 
           (   
 
 
  )   (3) 
             ( 
 
 
  )   (4) 
By the definition of an exponential time constant, T1 is the time it takes for 63% of Mz to return 
to its equilibrium magnetization Mz(0) along the B0 axis (1.3). On the other hand, T2 is the time 
constant of a decaying exponential so it is the time it takes to reach 37% (or lose 63%) of the 
initial transverse magnetization, Mxy(0). Both processes, occurring simultaneously, are graphed 
together in Figure 7. Note that in Figure 7, the growth and decay of each exponential process is 
not the same.  T2 decay occurs 5 to 10 times faster than T1 recovery.  
Figure 6
11
. (Rotating Frame) After the RF 
pulse is turned off, the transverse vector 
Mxy begins to decay (T2 relaxation) and 
the longitudinal component Mz recovers 
(T1 relaxation). The two processes occur 
simultaneously, but are independent of 
each other.  
Figure 7
11
. The rate of decay of transverse magnetization (T2) is faster than 
recovery of longitudinal magnetization (T1). Relative T1 (red) and T2 (blue) 
relaxation times are indicated by vertical lines. 
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Because NMR signal intensity is a function of relaxation time, natural contrast in MR images 
arises from the unique T1 and T2 times of different tissues in the body. Moreover, the contrast 
among tissues can be optimized by adjusting parameters in MR pulse sequences (section 1.1.3) 
and/or by using contrast agents (section 1.2). Table 1 lists typical T1 and T2 times of several 
tissues in the body. In order to understand why particular tissues have smaller or bigger T1 and 
T2 values, it is important to briefly discuss the physical mechanisms responsible for T1 and T2 
relaxation.  
 
             Table 1. T1 and T2 relaxation times at 1.5 T 
14
 
Tissue T1 (ms) T2 (ms) 
Cerebrospinal Fluid (CSF) 2400 600 
Fat 270 80 
Cartilage 1030 40 
 
Just as its name implies, spin-lattice (T1) relaxation involves transfer of energy between 
excited nuclei spin states and the surrounding ―lattice‖ of other nuclei in the local environment to 
restore the distribution of spin states predicted by the Boltzmann Distribution. Energy transfer is 
most efficient, and thus most significant, when the natural motional frequencies
[3]
 of nuclei are at 
the Larmor frequency. Natural motional frequencies arise from random translational, vibrational, 
and rotational movement of molecules in solution and can generate an oscillating magnetic field 
due to the movement of charged particles. When the frequency of the oscillating field is equal to 
the energy difference between states (i.e. Larmor frequency), a non-radiative form of stimulated 
emission allows excited spin states to relax down to their ground state. Spontaneous emission of 
                                                          
[3]
 Natural motional frequency, which is influenced by the chemical environment of the hydrogen nuclei, should not 
be confused with precessional frequency, which is a function of the Larmor frequency and magnetic field strength 
(see equation 2). 
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excited spin states is not significant in NMR because it is proportional to the third power of the 
emission frequency, which is in the low radiofrequency range.  
Because T1 depends on molecular movement, it is influenced by the mobility of the 
lattice. Water protons in Cerebrospinal Fluid (CSF), a colorless fluid around the brain and spinal 
cord, for example, have very high natural motional frequencies and water protons in cartilage, a 
compact tissue, have very slow motional frequencies. In both cases, the motional frequencies do 
not match the Larmor frequency, resulting in inefficient (slow) T1 relaxation. Fat, on the other 
hand, has protons with natural motional frequencies very close the Larmor frequency, causing 
efficient (fast) T1 relaxation (Table 1). 
Unlike spin-lattice relaxation which involves a change in energy of spin states, spin-spin 
(T2) relaxation describes the change in phase of magnetic moments after the application of the 
RF pulse. In spin-spin relaxation, which is often referred to as an entropic process, nuclei with 
magnetic moments that are lined up in the transverse plane after the RF pulse get out of phase 
due to a) local spin-spin interactions and b) inherent inhomogeneity in the external magnetic 
field. In the case of spin-spin interactions, small magnetic fields created by proximal spins 
aligned with or against B0 increase or decrease the overall magnetic field ―felt‖ by individual 
spins, respectively, causing spins to get out of phase over time as they take on a range of 
precessional frequencies according to equation (1). In addition, there will always be some 
variation in the external magnetic field that causes protons in one region to precess at a different 
Larmor frequency than in another region, contributing to spin dephasing. It is possible to 
measure the relaxation time due solely to spin-spin interaction (T2) or both spin-spin and 
external magnetic field inhomogeneity (T2*). T2, a fixed value for a specific tissue, and T2* are 
related through the deviation present in the external magnetic field (ΔB) and the proton 








       (5)15 
Because T2* takes into account ΔB and spin-spin interactions, T2 > T2*. 
Since T2 time is a function of how fast proton spins dephase due to interactions between 
spins, it depends on the molecular environment of protons. In pure water, for example, the 
interatomic distance between protons is relatively large due to the geometry of the water 
molecule and spin-spin interaction is therefore minimal. Generally, the more compact the tissue, 
the more spin-spin interactions take place, leading to shorter T2 times. This explains the T2 
times for CSF > Fat > Cartilage in Table 1. 
1.1.3 Pulse Sequences & Image Construction 
 
In order to improve contrast and obtain spatial information from multiple FIDs, specific 
MRI pulse sequences – protocols that specify the timing and strength of RF pulses (and often 
magnetic field gradients) – are used to collect signal during an MR imaging session. The two 
main parameters of a pulse sequence are Time to Repetition (TR) and Time to Echo (TE). TR is 
the time between consecutive excitation RF pulses (usually 90º) and TE is the time between the 
excitation pulse and collection of signal from a FID called an echo
[4]
. The TR and TE intervals 
for a common MR pulse sequence called a spin-echo are shown in Figure 17 in section 1.2.3. 
It is important to remember that unlike the fixed values
[5]
 T1 and T2, TR and TE can be 
adjusted by the operator. Thus, both sets of variables along with the number of mobile protons, 
N(H), factor into overall signal intensity: 
                        
  
        
  
     (6) 
 
                                                          
[4]
 Spatial-encoding steps (Figure 8) do not allow measurement of FID immediately after the RF pulse so signal is 
usually collected at some time (TE) after the pulse. In order to do this, often refocusing 180° RF pulses are applied 
to generate an ―echo‖ of the original FID. See discussion of the spin-echo pulse sequence in section 1.2.3. 
[5]
 Except when T1 and T2 times are shortened with contrast agents (see section 1.2) 
Rana 15 
 
By appropriately adjusting TR and TE, it is possible to see from equation (6) that more or less 
weight can be given to signal from T1 or T2 relaxation processes. So-called T1-weighted images 
generally have a short TE and short TR (TE < 30 ms, TR < 1000 ms) to maximize signal from 
longitudinal relaxation while T2-weighted images have a long TE and long TR (TE > 80, TR > 
2000 ms) to capture signal largely from transverse relaxation
16
.  
 Before FID signals obtained using a specific MR pulse sequence can be processed into an 
image, they need to be spatially encoded. That is, there needs to be a way to specify the origin of 
the received signal in three-dimensional space. This is achieved by applying gradients – linearly 
varying magnetic fields – in three dimensions (Figure 8).  
 
Initially, a gradient coil varies the magnetic field along one of the three dimensional axes (x, y, 
or z) during the RF excitation pulse. Because the Larmor frequency varies with magnetic field 
strength (     ), the gradient (G) creates a position-dependent spin (ω*) along the axis (z): 
                                                  (7)
12
 
                    
Figure 8
11
. Spin-echo pulse sequence 
diagram and associated gradients denoted as 
Gz (Slice-Select), Gy (Phase-Encoding), and 
Gx (Frequency-Encoding). The rectangle is 
the symbol for a linearly varying gradient. 
The unique symbol for the phase-encoding 
gradient (Gy) indicates the multiple phase-
encoding steps that must be made in a single 
acquisition (a separate TR is needed for each 
phase-encoding step).  
Rana 16 
 
This gradient, applied along the z axis in Figure 8, is called a slice-select gradient because if a 
RF pulse with a narrow bandwidth is applied to a sample, only nuclei in a particular ―slice‖ of 
the linearly varying B0 will have the appropriate Larmor frequency to be excited. The phase-
encoding gradient (applied after the excitation RF pulse) and the frequency-encoding gradient 
(applied during the readout, or, time the echo is formed) are the other two gradients applied 
along the remaining axes (y and x in Figure 8), respectively, allowing the spatial information to 
be collected along these axes in the same manner as outlined in equation (7). The final step is to 
Fourier transform the spatially-encoded two-dimensional array of FID signals from the time to 
frequency domain (note that in equation (7) position corresponds to frequency) to create a 2D 
MR image.   
1.2 Contrast Agents & Molecular MRI 
 
Since the development of MRI in the 1970s, chemical compounds clinically referred to as 
―contrast agents‖ have been used to selectively improve contrast of specific tissues in anatomical 
MR scans. In general, clinical contrast agents work by generating fluctuating magnetic fields to 
shorten relaxation times of water in certain tissues, creating brighter signal in T1-weighted scans 
and darker signal in T2-weighted scans according to equation (6). Although a contrast agent can 
usually shorten both T1 and T2 times, it is classified as either a T1 or T2 contrast agent 
depending on which type of contrast it produces more effectively. Chelates of paramagnetic 
Gd(III) and polymer-coated SPIO particles are common T1 and T2 clinical contrast agents, 
respectively. SPIOs in particular, due to their nanomolar sensitivity
[6]
 and high-contrast 
capabilities, have emerged as attractive platforms to build nano-scale probes that have the 
potential to make MRI a real-time diagnostic tool at the cellular and molecular level
17,18
. 
                                                          
[6]





The emerging field of ―molecular MRI‖ has attracted nanotechnology and biotechnology 
researchers to experiment with SPIO NP-based molecular probes. In one successful example of 
imaging breast cancer cells, SPIO NPs were conjugated with the HER2/neu antibody specific for 
antigens expressed by breast cancer cell lines
19
. A T2-weighted ex vivo ―phantom‖ MRI study 
showed noticeable negative contrast (i.e., signal darkening) in the cancer cell lines treated with 
the SPIO-conjugated-HER2/neu antibody, highlighting the ultra-sensitive detection capabilities 
of SPIOs in MRI (Figure 9). 
 
 
In addition, conjugated SPIOs were found to be biologically nontoxic at the test concentrations, 
making them an even more attractive probe for biomedical applications
19
. The following sections 
provide a chemical-physical background of SPIOs and their T2 relaxation mechanism.  
1.2.1 Superparamagnetic Behavior20,21 
SPIO contrast agents are colloidal suspensions of nano-size SPIO crystals. The most 
common SPIOs are magnetite (Fe3O4) and maghemite (γ-Fe2O3). Ferromagnetic materials, bulk 
magnetite and maghemite are composed of magnetic domains (Weiss domains) separated by 
Bloch wall transition regions. Each domain is uniformly magnetized due to the alignment of 
Figure 9
19
. T2-weighted MR images of various breast cancer cell lines treated with Mn-
doped SPIO nanoparticles (MnMEIO) conjugated with the HER2/neu antibody. Negative 
contrast increases with an increase in HER2/neu expression. 
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magnetic moments arising from unpaired electron spins in the SPIO crystal lattice
[7]
. When an 
external magnetic field is applied, the domains orient parallel to the field, producing a high 








An interesting phenomenon occurs for nano-size magnetite and maghemite crystals. Formation 
of Bloch walls becomes thermodynamically unfavorable for particles ~ 14 nm and below and 
each crystal acts as a single domain with superparamagnetic behavior
[8]
. As the name implies, 
superparamagnetic crystals have enhanced paramagnetic behavior. That is, they have a greater 
magnetic susceptibility (the degree of magnetization induced by external magnetic field) than 
                                                          
[7]
 This is a consequence of long-range ordering phenomena governed by quantum mechanics.  
[8]
 This sets a functional limit on the size of iron oxide cores in order for them to be superparamagnetic (<14 nm). 
Because iron oxide NPs are usually synthesized with a polymer coating, however, SPIOs are typically characterized 
in terms of their overall particle diameter, which can range from tens of nanometers to micrometers.  
Figure 10
21
. Bulk ferromagnetic 
material consists of many magnetic 
domains. When B0 = 0, the domains 
are oriented randomly, producing zero 
net magnetization (left). When B0 is 
turned on, domains orient parallel to 
the field and net magnetization is 
produced (right).  
Figure 11
21
. Magnetic behavior of (A) 
paramagnetic and (B) ferromagnetic material in 
an external magnetic field (the B vs. M curve for 
a superparamagnetic material is drawn in red). 
The curves represent induced magnetization M 
as a function of the applied field B. Paramagnetic 
material has non-interacting spins (lower left) 
while ferromagnetic/superparamagnetic material 




paramagnetic materials. This is due to the fact that magnetic moments arising from unpaired 
electron spins in paramagnetic materials align with the external magnetic field independently (as 
opposed to positive interaction among domains in ferromagnetic/superparamagnetic materials), 
resulting in lower susceptibilities than superparamagnetic materials (Figure 11). It is notable in 
Figure 11 that ferromagnetic materials can possess a large magnetization even in the absence of 
an external field (i.e. when B = 0 there is a non-zero value of M). Both superparamagnetic and 
paramagnetic materials differ in this regard and do not have any magnetization remaining once 
removed from the external field. Instead, thermal energy maintains random orientation of the 
domains in SPIOs, preventing their aggregation when the field is turned off.   
1.2.2 SPIO-Induced T2 Relaxivity 
SPIO magnetic moments induced by the external magnetic field perturb the T2 relaxation 
of protons in their vicinity. Because magnetic fields are distance-dependent, protons diffusing 
near SPIOs experience more rapid dephasing of their spins than protons further away, resulting 
in a shorter T2 time for the nearby protons that corresponds to a darker region in a T2-weighted 










. (Left, lower panel) MR image of tissue without 
SPIO contrast agent; (Right, lower panel) MR image of 
tissue in the presence of SPIO particles.  
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A parameter called the molar relaxivity is generally measured (section 1.2.3) to evaluate 
the efficiency and effectiveness of contrast agents like SPIOs. The molar relaxivity (r), expressed 




, is a contrast agent-specific parameter that takes into account the contrast 
agent concentration [CA] and relaxation rate (R2 or R1)
21
. T2 molar relaxivity (r2) is defined as: 
 
   
  
[  ]
        
 
  
   (8) 
Table 2 lists the r2 values for several SPIO-based clinical contrast agents.  
Table 2
18
. Size, composition, and molar relaxivity value for conventional SPIO contrast agents.   
Name SPIO Core Size 
(Total Size) 





Feridex ® 5-6 (80-150) nm Dextran 100 
Resovist ® 4.2 (62) nm Carbodextran 151 
Sinerem ® 4-6 (20-40) nm Dextran 53 
 
The range of values in Table 2 reveals relaxivity is a function of many variables, including size, 
composition, and surface chemistry of the contrast agent. Similar relaxivity values, for example, 




 were reported for both 10 nm SPIO NPs coated with a hydrophilic 
polymer and 30 nm SPIO NPs coated with a hydrophobic polymer, which highlights the complex 
interplay of size and coating composition on overall relaxivity
22
. It should also be noted that the 
expected linearity of R2 with [CA] according to equation (8) depends on the spatial distribution 
and the aggregation state of particles and may not always be observed
7,21,23
.  
 There are two major physical mechanisms that govern relaxivity: inner-sphere and outer 
sphere relaxation
24
. Inner sphere interactions take into account direct bonding and coordination 
between the solvent and contrast agent. Outer sphere interactions, on the other hand, characterize 
long-range interactions due to diffusion of solvent in the magnetic field generated by the contrast 
agent. Contrast agent-induced relaxation rates for T1 and T2 processes can be written in terms of 
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outer and inner sphere interactions. Unlike T1-based Gd(III) contrast agents, SPIOs do not have 
coordination sites for water, making inner sphere relaxation negligible. Thus, the relaxation rate 
for protons diffusing in the proximity of SPIOs is largely due to outer sphere relaxation
25
. 
To gain insight into outer sphere relaxation, LaConte et al. developed a Monte Carlo 
model to simulate the independent effects of the distance of water from the SPIO center (water 
exclusion radius) and retention of water in a hydrophilic coating around the SPIO core (slow 
compartment radius) on the relaxivity of SPIOs. Results from the simulation show that as the 
water exclusion radius increases there is a sharp decrease in R2, but as the slow compartment 




These opposing trends make chemical sense: the farther away water molecules are (exclusion 
radius), the more excluded they are from the distance-dependent dephasing induced by the 
magnetic moment of the SPIOs. On the other hand, the thicker the hydrophilic coating layer, the 
more intermolecular interactions there are to retain water for a longer time in the proximity of the 
SPIO core (i.e., diffusion coefficient of water becomes slower). Notably, when R2 was plotted as 
a function of both slow compartment and exclusion radii, it better approximated empirical data 





. La Conte et al. modeling and computer simulation of SPIO relaxivity for (a)  exclusion and (b) slow 
compartment radii models. 
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 In addition to empirical-modeling approaches, outer-sphere theoretical calculations have 
been performed. A derivation of outer sphere theory
27
 yielded an expression for the T2 relaxation 
rate (1/T2), which is simplified below, 
 
  
      
    
[ ]
  
 {       }  (9) 
where μ is the magnetic moment of the NP, γ1 is the gyromagnetic ratio of protons in water, NA is 
Avogadro‘s number, M is the molarity of the NP, r is its radius, D is the relative diffusion of the 
particle and the water, and jn(ω, τ) are Fourier transformed correlation functions (spectral density 
functions) of particle-water magnetic dipole interactions due to diffusion
18
.  
Previous studies have taken advantage of the fact that R2      to synthesize SPIOs with 
bigger magnetic moments in order to increase R2. In particular, there are two common ways to 
maximize μ: 1) increase the size of the SPIO core and 2) dope the SPIO crystal lattice with 
paramagnetic elements
18
. The μ size-dependence arises from misaligned spins that form around 
the surface of smaller NPs and decrease the overall magnetic moment of the crystal. As the 
diameter of the particle increases, this ―spin-canting effect‖ is less apparent, resulting in an 
increased μ (Figure 14)18,19. Doping the SPIO lattice with magnetically susceptible elements such 
as Mn, Co, and Ni has also been shown to increase μ by altering the electron spin configuration 
in the lattice
19
.   
IFigure 14. (A)
18
 Spin-canting decreases overall μ for smaller SPIO particles (B)19 Relaxivity increases 





. (A) The effective magnetic field Be(t) experienced by a water molecule due to molecular motions 
varies over time; (B) A time correlation function G(τ) of fluctuations in (A) produces an exponential decay function 
from which the correlation time, τc, can be calculated; (C) The spectral density function j(w) is twice the Fourier 
transformed correlation function  
n our study, commercially-synthesized 10 nm FexOy NPs are used for the SPIO cores. Although 
a co-precipitation synthesis
28
 for FexOy SPIOs has been previously explored
4,5
, the commercial 
product offers a more convenient source of SPIO cores to optimize surface coating procedures.  
These 10 nm cores are also ideal for biocompatibility reasons. Because 50-100 nm NPs are ideal 
for cellular uptake and selective biodistribution in the body
29
, a 10 nm core offers ample 
―building room‖ for coating and future functionalization. With this in mind, increasing the size 
of the SPIO core to improve relaxivity is undesirable. 
Returning to equation (9), it is also apparent that R2 is a function of Fourier transformed 
correlation functions, jn(ω, τ). These correlation functions parameterize the random molecular 
motions that lead to fluctuating magnetic fields and ultimately cause spin dephasing. From the 
correlation function, a correlation time constant (τ) can be calculated, which is a measure of how 
fast (small τ) or how slow (large τ) the fluctuations are taking place (Figure 15).  
 
For SPIO-induced T2-relaxation, there are three relevant correlation times:
21
 the 1) rotation of 
magnetization within the SPIO particle (τN), 2) rotation of the SPIO particle and magnetization 
as a whole (τB), and 3) diffusional motion of water in the proximity of the contrast agent (τD = 
R
2







Because τD  R
2
, larger particles (μm) generally have a long correlation time (i.e., NPs assumed 
to be static relative to water molecules) and smaller particles (nm) have a short correlation time 
(i.e. diffusion of NPs is assumed to be very fast). On the basis of size alone, then, it is plausible 
that coating the iron-oxide cores (i.e. increasing the overall size of the particle) will increase the 
correlation time and, thus, decrease the diffusion contribution to T2 relaxation.   
1.2.3 Measuring T2 Relaxivity11 
According to equation (8), there are two quantities that must be measured to obtain r2: 
[SPIO] and the T2 relaxation time. The [Fe] in SPIOs is generally used as the molarity 
concentration value for SPIO-based contrast agents and can be determined spectroscopically
30
. 
The T2 relaxation time can be obtained from signal intensity measurements of MR images 








. T2 relaxation is due in 
part to diffusion of water protons in the 
fluctuating magnetic field produced by 
the particle (τD), Neel relaxation (τN), 
and Brownian relaxation (τB). These 
molecular motions contribute to the 
spread of Larmor frequencies (Δω) 
experienced by nuclear spin states.  
Figure 17
11
. Spin-Echo Pulse Sequence and associated FID & Echo signals 
Rana 25 
 
First, a 90º excitation RF pulse flips the magnetization vector into the transverse plane. Recall, 
immediately after the RF pulse is turned off, the spin vectors are precessing in phase around the 
B0 axis. At a certain time τ after the spins get out of phase, a 180º RF pulse is applied. As its 
name implies, the 180º pulse reverses the spins in the transverse plane by 180º. The 180º pulse 
refocuses the spins, causing them to rephase as they precess in reverse direction. They reach 
maximum rephasing at time 2τ, producing a signal called an echo. Multiple 180º pulses can be 









The decay function can be fit to T2 portion of equation (6) to obtain the time constant, T2, from 
a linear plot of 1/T2 and ln(SI): 
                                  
 
  
      (10)31 
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Ultimately, the SE pulse sequence makes it possible to regain signal lost due to the external 
magnetic field inhomogeneity. Because T2 relaxation is an intrinsic property, only decay of the 




. Echo train produced by a dual-echo, spin-echo pulse sequence. T2 is the time 
constant for the echo train decay; T2* is the time constant for individual echoes.  
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2 Materials and Methods 
 
2.1 Functionalization of FexOy NPs 
A commercial water-based colloidal FexOy NP solution (Ferrotec EMG 304®, 4.5% v/v, 10 nm 
average size) was used as the SPIO NP core precursor for FexOy NP functionalization (FexOy@) 
with silica (SiO2) and/or poly(ethylene glycol) (PEG). Figure 19 is a flowchart of the syntheses 
explored in this study. The viscous EMG 304® colloidal suspension of FexOy NPs was typically 
diluted to create a 1.3% w/v stock solution (Ferrotec stock) with 18.3 MΩ·cm H2O (nH2O) or 
absolute ethanol (abs. EtOH).  
 
 
Figure 19. Flowchart of surface modifications attempted in this study on commercially-synthesized 10 nm FexOy 
NPs (EMG 304®). The section within Materials & Methods corresponding to each route is indicated in parentheses. 
 
2.1.1 FexOy@SiO2 NPs 
Silica-coated FexOy NPs (FexOy@SiO2) were prepared using: 
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1. The Stöber synthesis originally described by Ji et al.7 and adapted from Yayla5 (Stöber 
Method, section 2.1.1.1) or  
2. A reverse microemulsion modified-Stöber functionalization procedure adapted from Yi et 
al.
32
, Deng et al.
33
 , and Narita et al.
34
 (Microemulsion Method, section  2.1.1.2).  
2.1.1.1  Stöber Method 
An aliquot of aqueous Ferrotec stock solution was dissolved in nH2O + abs. EtOH + NH4OH 
(Sigma Aldrich 28% w/v) and sonicated for 2-4 minutes. Tetraethyl orthosilicate (TEOS, Sigma 
Aldrich, 99.9%) was then added under continuous stirring over a magnetic stir plate. Amounts of 
reagents typically used are given in Table 3. Contents were left to stir overnight (~12 hours) and 
SPIO products were collected over a magnet (Qiagen Cat # 36910). After the FexOy NP product 
visibly collected (dark brown pellet) next to the magnet, the supernatant was decanted and 2-3 
washing steps (re-suspend pellet in abs. EtOH and/or nH2O, sonicate, re-collect over magnet) 
were performed; the washed product was suspended in abs. EtOH.  
 
Table 3. Typical reagent amounts used in the Stöber Method for the synthesis of FexOy@SiO2 NPs. 
 
Reagent Amount 
Ferrotec Stock in nH2O 1.00 mL 
nH2O 500 μL – 2.60 mL 
Abs. EtOH 7.00 – 9.00 mL 
NH4OH (28% w/v) 875 μL 
TEOS (99.9%) 5.00 μL 
 
2.1.1.2 Microemulsion Method 
 
 
Cyclohexane (Mallinckrodt 99.0%) and Igepal© CO-520 (Sigma Aldrich) were stirred on a 
magnetic stir plate for 5-10 minutes. Next, an aliquot of the aqueous EMG 304® suspension was 
weighed and added to the cyclohexane-Igepal mixture, which was immediately sonicated for 3-5 
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minutes to establish a reverse emulsion phase. NH4OH (Sigma Aldrich 28% w/v) was added to 
the microemulsion and then left on an overhead shaker for one hour. Over continuous stirring, 
tetraethyl orthosilicate (TEOS, Sigma Aldrich, 99.9%) was added to the sonicated (3-5 min) 
NH4OH-microemulsion mixture. Contents were stirred on a magnetic stir plate for 1-24 hours
[9]
 
and the reaction was terminated by the addition of an equal volume of 1) abs. EtOH or 2) a 
solution of 10 μL PEG-silane (Polymer Source, Trimethoxy propyl-terminated PEG methyl ether 
420 MW) dissolved in 2.00 mL nH2O + 20 mL abs. EtOH or 3) a solution of 10 μL PEG-silane 
(420 MW) dissolved in 11 mL abs. EtOH. Products were collected and washed in same manner 
described in section  2.1.1.1 for the Stöber method. The quantities of reagents typically used are 
given in Table 4.  
 
Table 4. Typical reagent amounts used in the reverse microemulsion synthesis of FexOy@SiO2 NPs. 
 
Reagent Amount 
Cyclohexane 10 mL 
Igepal CO-520 0.5 mL 
Ferrotec EMG 304® 0.001 – 0.006 g 
NH4OH (28% w/v) 875 μL 
TEOS (99.9%)                   5.00 μL 
 
2.1.2 FexOy@PEG NPs 
An aliquot of the aqueous EMG 304® suspension was sonicated (2-5 min) and then stirred with 
a PEG-silane species (Polymer Source, Trimethoxysilane PEG methyl ether 1050 MW or 420 
MW) in abs. EtOH overnight. Alternatively, the PEG-silane species was added in place of TEOS 
in the reverse microemulsion synthetic scheme outline in section  2.1.1.2. Collection and washing 
steps for FexOy NPs were performed as described in section  2.1.1.1. A negative control 
functionalization was also done with a PEG-thiol species (Polymer Source, α-hydroxyl-ω-thiol 
                                                          
[9]
 Reaction times were varied for different trials 
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terminated PEG 2300 MW) to investigate efficacy of washing steps. Reagent amounts typically 
used are given in Table 5. 
 
Table 5. Typical reagent amounts used in the PEGylation of FexOy NPs. 
 
Reagent Amount 
Ferrotec EMG 304®* 0.01 – 0.05 g 
PEG-silane 1050 MW 0.02-0.05 g 
PEG-thiol 2300 MW 0.02-0.05 g 
PEG-silane 420 MW** 10 uL, 400 μL  
Abs. EtOH 5 mL 
*Approximate range inferred based on ―pinch‖ of viscous EMG 304® added 
**10 μL used in microemulsion method, 400 μL used in abs. EtOH functionalization 
 
2.1.3 PEGylation of FexOy@SiO2 NPs 
Silica and PEG FexOy NP functionalization was performed using the microemulsion reaction 
scheme described in section  2.1.1.2 with the following alteration: PEG-Silane (Polymer Source, 
Trimethoxysilane PEG methyl ether 420 MW) was added to the cyclohexane + Igepal + NH4OH 
reaction mixture (3.5 mL) simultaneously with TEOS (1.6 μL) in 2:1, 4:1, and 8:1 PEG to TEOS 
volume ratios.  
2.2 Physiochemical Characterization of NPs 
 
2.2.1 Transmission Electron Microscopy (TEM) 
 
Morphology and size of distribution of synthesized NPs were examined by electron microscopy 
(Phillips CM 10, 80 KV accelerating voltage) images. TEM samples were prepared by mounting 
1-3 drops of the sonicated nanoparticle solution (dissolved in abs. EtOH or nH2O) on a formvar 
400 mesh CU grid (Ladd Research) and allowing it to dry in air. TEM images were generally 
collected at 34,000× – 64,000× magnifications. A manual procedure was used to measure 
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particle size: a particle on the imaging screen was translated across the diameter of the 
nanoparticle and the translation distance was recorded by the instrument.  
2.2.2 FT-Infrared (IR) Spectroscopy 
IR spectra of FexOy@PEG and FexOy@SiO2 products and reactants were obtained to indirectly 
verify silica and/or PEGylation functionalization procedures. FT-IR measurements were carried 
out using a Perkin-Elmer Spectrum One FT-IR spectrometer with a universal ATR sampling 
accessory (scanning range: 650-4000 cm
-1





, a concentrated slurry of the NP solution dissolved in abs. EtOH was pipetted 
over the ATR crystal. IR spectra were collected on the solid sample after the EtOH evaporated 
(2-4 minutes) using air as the background scan (adapted from Yayla
5
). 
2.2.3 Dynamic Light Scattering (DLS) 
 
DLS (Malvern Nano-2S) data were used to obtain, when possible, a size distribution of the bare 
and functionalized FexOy NPs. Sonicated samples were filtered (2 μm Tuffyrn membrane filter) 
and DLS correlation and size data were obtained using the standard operating procedure (SOP) 
file FeOx.sop; collection parameters: 173º backscatter measurement, 120s equilibrium time, RI = 
2.940, Abs = 0.05 in ethanol at 25º C. Efforts were made to sonicate (2-5 minutes) NP sample 
solution (dissolved in abs. EtOH or nH2O) immediately prior to analysis to limit FexOy NP 
aggregation. 
 
2.3 Characterization of SPIO MR Contrast Effect (T2 Molar Relaxivity) 
 
                                                          
[10]
 S/N ratio can be improved by increasing signal or getting rid of noise. In this case, a concentrated slurry will 
allow a greater intensity signal, creating a greater difference between the signal and random, unwanted noise, 
resulting in an increased S/N. Other methods for improving S/N include: ensemble averaging, post-processing 
modifications (e.g. FT filter, boxcar averaging).  
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2.3.1 [Fe2+] Determination 
 
The [Fe] in FexOy NP samples for molar relaxivity calculations were obtained using either UV-
Visible Spectroscopy (UV-Vis) or Inductively Coupled Plasma-Atomic Emission Spectroscopy 
(ICP-AES). 
2.3.1.1  UV-Vis Colorimetric [Fe2+] Determination 
A spectrophotometric protocol developed by Oca-Cassio et al.
30
 was adapted to determine [Fe] in 
FexOy NP samples. In a borosilicate disposable test tube, a dilute aliquot (0.5 – 2 mL) of bare or 
functionalized FexOy NPs was acid digested with an equal volume of 70% w/w (15.7 M) HNO3 
(EMD Chemicals, ACS grade) overnight to displace oxygen from the iron ions in the crystal 
lattice. The solution turns from rust-brown to clear colorless or light yellow solution depending 
on [Fe]. Next, the acid-digested solution was buffered by adding 10% w/v sodium acetate (pKa = 





ions. Finally, an excess of 0.002 M o-phenanthroline (Fisher Scientific, ACS 
grade), a bidentate ligand that complexes with Fe
2+
 to form a bright red-orange compound, was 
added to the solution (Figure 20A & B). UV-Vis spectra (Varian Cary 500 Scan UV-Visible 
NIR) were collected in the 200-800 nm range using a quartz cuvette (l = 1 cm) to measure the 
peak absorbance of the complex (λ ~ 510 nm).  
 
 
Figure 20. A) Ferrotec dissolved in nH2O; B) Ferrotec digested with concentrated HNO3 and added to an excess of 
o-phenanthroline; C) The orange-red Fe(II)-Phenanthroline has a visible absorption λmax~ 510 nm. Using Beer-




Beer‘s Law (A = ɛcl) and a standard curve35 obtained with known [Fe] (Figure 21) were used to 
obtain [Fe
2+
] in NP samples from UV-Vis peak absorbance measurements. An example tris(1,10 




. Absorbance vs. concentration standard curve for the Fe
2+
- Phenanthroline complex (λmax ~ 510 nm). 








2.3.1.2  ICP-AES [Fe2+] Determination  
Bare and surface-modified FexOy NPs were acid digested in the same manner as described in 
section  2.3.1.1 for the preparation of Fe(II)-o-phenanthroline samples; however, for ICP-AES 
analysis, 70% (15.7 M) of high-purity HNO3 (OmniTrace Ultra) was used instead of ACS grade 
HNO3.  An aliquot of the acid-digested NP solution was diluted with nH2O to create a 2% w/w 
HNO3 solution in a 15 mL conical centrifuge tube (minimum 3mL volume). Atomic emission 
intensities (Optima 7000 DV ICP-AES spectrometer) of Fe
2+





 (40 ppm, 4 ppm, 0.4 ppm, 0.04 ppm, 0.004 ppm) were obtained at λem= 
238.204 nm. Output intensity values of standards were plotted as function of [Fe] in MS Excel to 




 standards were always run alongside NP samples. Therefore, a new standard curve was calculated for each 
batch of samples. This differs from the UV-Vis analysis in which [Fe] was calculated from a single standard curve 
shown in Figure 20. 
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create a standard curve and Beer‘s Law (A = ɛcl) was then used to calculate [Fe2+] in FexOy NP 
samples from sample intensity values.  
2.3.2 MRI Phantom Preparation 
 
Two methods for phantom preparation were explored. In the first method, agarose suspensions of 
FexOy NP samples in nH2O were prepared using the procedure outlined by Yayla
5
. In the second 
method, aqueous suspensions of FexOy NP samples in nH2O were prepared as outlined below. 
An equal volume (0.5 – 1 mL) of 3-5 serial dilutions (typically 0.03 mM to 0.3 mM) of FexOy 
NP samples in nH2O were pipetted into individual 2, 3, or 5 mm OD NMR tubes (Wilmad). In 
addition to a NMR tube containing pure nH2O, sample NMR tubes were either a) suspended in 
1.3 % w/v agarose gel doped with manganese in a conical 25 mL plastic centrifuge tube or b) put 




Figure 22. (A) A T2-weighted cross-sectional MR image of eight 2mm NMR tubes suspended in a phantom holder 
(B). Tubes in the circle contain varying [SPIO – bare or functionalized with PEG and/or TEOS] in nH2O; darker 
regions on MR image contain a greater [Fe]. The tube outside the circle contains pure nH2O. Imaging Parameters: 
TR = 3062 ms, TE = 20 ms, FOV = 4.00 cm, 1 Avg, MSME-T2-MAP, Bruker ParaVision. 
 
2.3.3 MRI T2 Relaxivity Studies 
 
In order to obtain the T2 relaxation time of samples for molar relaxivity calculations, MR images 
(400 MHz Bruker Avance NMR spectrometer, 9.4T, vertical bore, 2.4 G/cm/A gradient strength) 
were acquired of the FexOy NP phantoms (section  2.3.2). MR Images were acquired with Bruker 
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Paravision 4.0 MSME-T2-MAP pulse sequence; optimized parameters were TR = 3062 s, TE = 
10, 20, 30, 40, … , 600 ms, 60 echoes, 1 avg, 4 x 4 cm FOV, 128 x 128 matrix. An example MR 
image is shown in Figure 22A. T2 values were determined by fitting an exponential decay curve 
to a plot of TE vs. Signal Intensity for each [FexOy] using the Image Sequence Analysis (ISA) 
tool in Paravision as outlined in the Appendix of Yayla
5
. In MS Excel, molar relaxivity values 
were obtained by finding the slope of [Fe] (determined using UV-Vis or ICP-AES as outlined in 



















3 Results and Discussion 
 
3.1 Surface Modification of FexOy NPs 
 
Commercially available SPIOs were coated with PEG and/or silica to 1) afford additional 
protection against oxidation of the iron oxide surface
36
 in vivo and 2) facilitate future surface 
functionalization with anti-tumor moieties by introducing easily tunable surface chemistries. 
Surface modification of the SPIO nanocores is currently required for clinical approval of 
SPIOs as MRI contrast agents. A thin coating can alleviate particle aggregation, afford greater 
biocompatibility, and, in the case of PEG, can increase the blood circulation time of SPIOs in 
vivo
37
. For example, Feridex I.V. ®, the first SPIO-based MRI contrast agent clinically approved 
for imaging liver lesions, is a dextran-coated colloidal suspension of SPIOs. The biocompatible 
carbohydrate coating effectively stabilizes agglomerates of SPIOs in aqueous dispersions, but its 
branched surface is prone to inter-particle cross-linking and it is therefore not a suitable scaffold 
for anchoring other functional groups. To serve as an effective chemical scaffold, a protective 
coating such as silica or PEG, with uniform and well-known surface chemistry, is desired. 
3.1.1 FexOy@SiO2 NPs 
 
 Hydrophilic silanol groups (-Si-OH) on the surface of silica can serve as versatile covalent 
and electrostatic anchor sites for various ligands. Silica-coated iron oxide NPs (SCIOs) have also 
shown low toxicity in vitro, a promising biocompatibility consideration for their use as targeting 
and imaging agents in vivo
38
. Silica is also net negatively charged at pH = 7, which contributes to 
anionic repulsive stabilizing forces in solution. Notably, the main difference between metallic 
gold – another scaffold-protective interface for SPIOs being investigated by Lisa Jacobs ‗12 at 
Wellesley College
39
 – and the ―softer‖ polymeric matrix of silica is the nature of the chemical 
linker groups on the surface. The readily thiolated surface of gold exposes Au-thiol (-Au-SH) 
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groups whereas condensation of the silica exposes Si-hydroxyl (-Si-OH) groups. Both are well-
understood and uniform surfaces that can covalently tether common functional groups like 
amines and carboxylic acids
40
.   
 With these considerations in mind, a sol-gel procedure called the Stöber method was 
adapted from Ji et al.
7
 to coat SPIO cores (Ferrotec EMG 304®, 10 nm average size) with a thin 
layer (1-10 nm) of silica. In a sol-gel procedure, a colloid solution (sol) serves as a precursor for 
the formation of a polymeric matrix or distinct particles (gel). The source of silica in the Stöber 
method is a silicon alkoxide species (tetraethylorthosilicate –  TEOS), which condenses onto the 
colloidal SPIO cores in a basic alcohol/water mixture to form the silica coating (Figure 23).  
 
Figure 23. Ferrotec SPIO nanoparticles (EMG 304®) were coated with silica using the sol-gel process. A silica pre-
cursor, TEOS (tetraethylorthosilicate), replaces an unspecified anionic capping ligand on the SPIOs (not shown) and 
condenses onto the surface of the FexOy nanoparticle (shaded sphere) under basic conditions.  
Hydroxyl groups on the surface of iron oxide react with the silica precursor and replace any non-
covalent capping ligands to form a covalent Fe-O-Si bond. In many Stöber processes described 
in the literature, SPIOs are pre-synthesized with a weak capping ligand (most commonly oleic 
acid) to alleviate aggregation prior to and during silica coating
41
. Although precise composition 
of the Ferrotec EMG 304® SPIO suspension is proprietary information, the MSDS indicates a 
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0.5-1.5% v/v anionic ―water soluble dispersant‖ is present to stabilize SPIOs42. If this 
―dispersant‖ stabilizes the SPIOs non-covalently, excess silica precursor in the synthesis should 
displace the dispersant to form the covalent Fe-O-Si bond. Notably, the relatively mild 
EtOH/water reaction conditions and ability to incorporate aqueous SPIO suspensions in a 




3.1.1.1  [TEOS] affects monodispersity and size of SCIOs  
 The amount of TEOS (0.05-10% v/v) was varied in attempt to control the thickness of the 
silica layer in accordance with reports by Yayla
5
 and Deng et al.
33
 that the thickness of the silica 
coating can be controlled by adjusting concentration of the silicon alkoxide precursor. Because 
silica is visually more transparent than iron oxide under a TEM beam, TEM images of the NPs 
were obtained to assess the size and morphology of the desired core-shell SCIOs.  
 At the lowest concentration of TEOS (0.05% v/v), a thin (5-10 nm) silica coating was 
evident in the TEM image, however aggregation significantly obscured the particle morphology, 
resulting in a non-uniform core-shell structure and a wide particle size distribution (Figure 24). 
 
Figure 24. TEM images of core-shell silica coated Ferrotec SPIOs reported by Ji et al.
7
 (A) and in this study (B) 
using a sol-gel process (VE:W = 5; 28% wt. NH4OH 8.75% v/v; 12 hour reaction time) with 0.5% v/v TEOS (A) and 
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0.05% v/v TEOS (B). In (A) there is a relatively uniform transparent layer of silica around darker iron oxide cores 
(indicated by the arrows). In (B) the core-shell structure is only evident in some regions (one highlighted by the 
white box inset); significant aggregation and a wide size distribution is also evident.   
Figure 24 also highlights another interesting phenomenon. Using nearly identical sol-gel reaction 
conditions, Ji et al.
7
 obtained more monodisperse SCIOs at a higher [TEOS] (Figure 24A) than 
used in this study (Figure 24B). In their silica sol-gel characterization studies, Deng et al.
33
 also 
reported more monodisperse and spherical SCIOs at high [TEOS] relative to low [TEOS]. One 
plausible explanation for these differences may be that at lower [TEOS], the silanol-SPIO 
interaction is not sufficient to overcome inter-particle SPIO interactions arising from the 
unspecified capping agent. As the [TEOS] is increased, however, Le Chatelier‘s principle favors 
the silanol-SPIO interaction, which results in more well-defined core-shell structures. The 
observed trade-off between particle size and monodispersity motivated alternative modifications 
to the Stöber method to selectively tune the size of the silica coating without compromising 
uniform size distribution of particles. 
3.1.1.2  Solvent composition influences SCIO particle morphology 
 Deng et al.
33
 reports that the concentration of any reagent in the sol-gel process (i.e. 
TEOS, NH4OH, EtOH, and/or H2O) can be altered to fine-tune particle dispersion and 
morphology. In the context of the sol-gel reaction conditions used in this study, the most 
compelling result from the Deng et al. study was the observation of irregular SCIO particle 
morphology when the volume ratio of ethanol to water (VE:W) was lower than 2 or higher than 4. 
Given that the VE:W adapted from the Ji et al. protocol
7
 is outside of this range (VE:W = 5), the 




Figure 25. TEM images of silica-coated Ferrotec; EtOH/H2O (VE:W = 2-6, TEOS 0.05% v/v, 28% wt. NH4OH 
8.75% v/v; 12 hour reaction time).  
Figure 25 shows representative TEM images of SCIOs synthesized with various VE:W  ranging 
from 2-6. While differences in morphology are visually evident among the different VE:W, it is 
clear from the aggregation and non-uniform particle size in all three cases that the problem of 
monodispersity is still unresolved. Notably, however, VE:W  = 4 provides the best of the three 
particle morphologies. Aggregation appears to be most problematic in VE:W  = 6 and unreacted 
silica – a phenomenon Deng et al. term ―phase separation‖ – appears to dominate in VE:W  = 2. 
This result can be rationalized by the fact that SPIOs are more stable in the water than EtOH 
while the silica precursor, TEOS, dissolves more readily in EtOH. Thus, if there is too much 
water (low VE:W  value), silica may undergo a phase separation and condense onto itself in the 
EtOH as it appears to have done in VE:W  = 2. On the other hand, if there is too little water (high 
VE:W  value), irregular particle size and morphology may result because SPIOs are not dispersed 
efficiently in the solvent
33
. In VE:W  = 4 there is evidence of core-shell structure without phase 
separation or excessive aggregation. However, the SCIOs lack spherical and particulate 
morphology; instead they are associated with a matrix of silica. Given that a low [TEOS] was 
used in this reaction (0.05% v/v), this matrix effect may be due to the same trade-off between 
overall SCIO size and morphology observed when varying [TEOS]. In order to investigate this 
further, the same VE:W  = 4 reaction conditions were repeated with a higher (0.5% v/v) and lower 




Figure 26. TEM images of silica-coated Ferrotec using (A) 0.009% TEOS and (B) 0.5% TEOS; E/W = 4, 28% wt. 
NH4OH 6.25-8.75% v/v. SPIO cores are visible as dark dots (denoted by arrow) coated by a more transparent silica 
layer. 
Indeed, a more globular and particular core-shell structure is observed at the higher [TEOS] than 
the lower [TEOS], suggesting the size-monodispersity trade-off is a persistent limitation of the 
Stöber process. One note that should be made of this analysis and TEM analysis as a whole is 
that it is difficult at times to differentiate between SPIO cores and the silica layer, especially at a 
low [TEOS] (Figure 26A). This may result from not using enough TEOS to see any appreciable 
silica coating and/or poor TEM resolution of the SPIO crystal lattice (Nolan T. Flynn, Personal 
Communication). It is plausible, for example, that the iron oxide crystal lattice is oriented in 
different ways relative to the electron beam path of the TE microscope, which may result in 
different intensities of ―darkness‖ that are evident in TEM images of SPIO cores. Despite 
instrumental limitations, however, there was ambiguous and poor evidence from TEM even at 
moderate [TEOS] that the sol-gel process was yielding a monodisperse and thin layer of silica on 
the SPIO cores.  
3.1.1.3  PEG affects DLS (but not TEM) SCIO particle size in microemulsion 
In attempt to overcome limitations of the sol-gel process, SPIO cores were also coated 
with silica using a water-in-oil inverse microemulsion process. Narita et al. underscore that while 
the sol-gel process has the advantage of being a relatively simple reaction procedure, it occurs on 
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the timescale of several hours and is too fast to offer efficient size control
34
. On the other hand, a 
slightly more involved microemulsion procedure can offer better morphological control by using 
a non-ionic surfactant to mediate the silica coating around iron oxide cores in reverse micelles. A 
reverse emulsion phase (Figure 27) was established by replacing the H2O/EtOH solvent in the 
Stöber method with an organic solvent (cyclohexane) – the ―oil‖ component – and a non-ionic 
surfactant (Igepal CO-520) to dissolve the ―water‖ phase NPs.  Given the reported success of the 
microemulsion process in synthesizing small monodisperse silica-coated metal NPs (< 20 nm)
43
, 




. Reverse microemulsion synthetic scheme for FexOy@SiO2 NPs in cyclohexane.  
 
During the initial microemulsion synthesis, the TEM was under repair and SCIOs were 
analyzed with DLS and FT-IR spectroscopy. DLS measurements, which give the hydrodynamic 
radius of small particles in solution, have proven difficult for SPIOs because despite the ―water 
soluble dispersant,‖ they readily aggregate in solution, especially at higher concentrations. DLS 
measurements for bare SPIOs, for example, were only successfully obtained at or below 4 x 10
-3
 
mg/mL of the Ferrotec suspension. Occasionally DLS measurements were not consistent and/or 
did not meet quality criteria required by the analysis software. Therefore, DLS data should be 




Figure 28. DLS measurements of overall SCIO size after (A) Microemulsion synthesis and (B) Post-microemulsion 
addition of PEG-Silane (MW = 420); note that values shown are ―calculated‖ and further averaging should be done 
to obtain a standard deviation to more accurately report values.  
The initial SCIO particle diameter reported for the microemulsion synthesis by DLS was 
107 nm. Given the DLS diameter of uncoated SPIO cores is ~ 20 nm, a ~100 nm particle size 
indicates a ~ 40 nm corona of silica around the SPIO core (Figure 28A). Though it is reasonable 
to expect the hydrodynamic diameter of particles in solution to be larger than size measurements 
of dry samples obtained from TEM images, a 40 nm increase far exceeds the increase predicted 
by the formation of a thin (5-10 nm) coat of silica, suggesting the particles might be aggregating 
in solution. To probe this further, a 10 μL aliquot of PEG-silane (MW = 420) was sonicated and 
stirred with the post-reaction mixture. Because PEG lacks the reactive alkoxide terminal groups 
on TEOS, it was expected to alleviate inter-particle aggregation resulting from potential cross-
linking of TEOS. The 92 nm DLS diameter of the PEGylated SCIOs is expectedly smaller than 
the unPEGylated SCIOs (107 nm), however this 15 nm decrease is not significant enough to 
verify the deposit of < 20 nm silica layer (Figure 28B).  
 Moreover, PEG‘s hydrophilicity may also increase the hydrodynamic diameter of the 
particle and therefore the observed decrease in particle diameter post-PEGylation might be less 
than expected if another, less hydrophilic, stabilizing agent been added to relieve aggregation. 
That is, SCIO particle diameter post-PEGylation cannot be directly correlated with thickness of 
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deposited silica layer because size increase due solely to PEGylation of the SPIO surface could 
not be taken into account.  
Nonetheless, PEG‘s reported ability to prolong the half-life of drugs in the body9 and its 
potential to serve as an Avidin-biotin linker for additional functionalization of the nanovehicle 
through a modified biotinylated-PEG species motivated further studies with the microemulsion 
silica synthesis. Park et al. were successful, for example, in depositing a thin (4.5 ± 1.0 nm) layer 
of silica on SPIO cores in the microemulsion procedure by adding a long-chain alkane silane that 
lacks the reactive alkoxide groups on TEOS
44
. One reasonable interpretation of adding the alkane 
silane is that the unreactive alkane terminus limits the amount of silica that can condense on the 
NP surface and alleviates inter-particle condensation and aggregation. By the same logic, a PEG-
silane species was added during or after microemulsion synthesis to see if similar results could 
be obtained.   
Due to poor S:N, the FT-IR spectrum in Figure 29 suggests, but does not confirm, the 
presence of a silica-PEG interface on the SPIO cores when PEG-silane (MW = 420) was added 
with TEOS during the microemulsion synthesis.  
 
 
Figure 29. FT-IR spectra of FexOy@SiO2 NPs and FexOy@(SiO2+PEG) NPs synthesized using the microemulsion 
method. Trimethoxysilane PEG (MW = 420) was added to PEGylated sample at the start of reaction with TEOS. 
Samples were washed/collected in EtOH and left to dry for 5-10 minutes on sample holder before IR spectra were 
obtained. Note appearance of (noisy) C-H stretch (2927 cm
-1
) and shifted Si-O stretch (1082 cm
-1





In Figure 29 there is (noisy) evidence of PEG sp
3
 C-H stretches that did not appear to be in the 
IR spectrum for the microemulsion silica synthesis without PEG. Moreover, the Si-O stretch in 
the PEGylated sample (1082 cm
-1
) is shifted slightly from the Si-O stretch from TEOS
34
 in the 
unPEGylated sample (1059 cm
-1
), which may also indicate the presence of the silane group from 
the PEG
[12]
. On the other hand, FT-IR spectra did not reveal any change in C-H or Si-O stretch 
regions when PEG was added after the microemulsion synthesis with the PEG/EtOH/nH2O 
terminating solution (Figure 30).  
 
 
Figure 30. FT-IR spectra of FexOy@SiO2 NPs synthesized using the microemulsion method and terminated with 
either EtOH or a PEG/nH2O/EtOH solution. Samples were dissolved in water and run with a water background scan. 
Note that no changes in vibrations are seen in C-H in Si-O stretch regions.  
Notably, it is hypothesized that the presence of water and its insolubility in the organic reaction 
media segregated the PEG from the SPIO cores to not allow sufficient (or any) PEG adsorption 
detectable by FT-IR. Post-reaction surface modification with PEG was repeated without water 
using a PEG/EtOH terminating step, but sample was too dilute to obtain readable IR spectra of 
this product. On an important side note, the silane (Si-O) stretches appear ―sharper‖ and more 
resolved in Figure 30 than in Figure 29. Differences in appearance of the stretch may be due to 
                                                          
[12]
 Another reason for the poor S:N and a notable complication of interpreting the spectra in Figure 29 is the relative 
amount of sample measured in each case. Because the PEGylated sample may have been more dilute, FT-IR data 
should be re-obtained to confirm PEGylation. Additionally, slight differences in the two spectra could also be 
attributed to an unequal amount of time given for the samples to ―dry‖ on the ATR crystal (thus, the possibility of 
seeing a signal from the solvent, EtOH) and this should be investigated further.  
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one or more factors: the phase of the sample (liquid vs. dry), number of averages, and different 
resolutions (cm
-1
) used to collect spectra. Future work should investigate optimum number of 
averages and resolution to achieve high-quality, resolved FT-IR spectra.  
 TEM analysis was performed on reactions 1) with PEG added during the reaction, 2) 
terminated with PEG/EtOH, and 3) terminated with EtOH only.  
Upon visual inspection, there was no apparent difference in particle size and morphology 
among samples with different volume ratios of PEG to TEOS (VP:T) added during the reaction in 
TEM images (Figure 31).  
 
Figure 31. TEM images of FexOy@(SiO2 + PEG) NPs synthesized using the reverse microemulsion method 
terminated with EtOH after ~ 24 hours with VP:T (PEG to TEOS volume ratio) = 2-8.  
 
PEG in the reaction media was hypothesized to limit aggregation and the amount of TEOS that 
condenses onto the surface of the SPIO, but VP:T = 2, 4, and 8 all have similar particle sizes and 
ambiguous core-shell morphologies. Furthermore, although overall particle size is < 20 nm; it is 
not obviously apparent that this is ―better‖ than the Stöber method in which similar aggregation 
was evident in TEM images. Because the silica coating is not uniform and distinct SPIO cores 
are difficult to visualize given considerable aggregation, evidence of PEGylation merits further 
investigation. Moreover, given the indirect FT-IR evidence of PEG on the surface and different 
molar relaxivity values (section 3.2.2) for the samples with different VP:T values shown in Figure 
31, there is evidence that surface chemistry of SCIOs is changing – it just may not be able to be 
detected using TEM.  
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TEM analysis also revealed no major qualitative differences between products terminated 
with PEG/EtOH or EtOH only. It was expected that SCIOs terminated with PEG/EtOH would be 
less aggregated and/or smaller than SCIOs terminated with only EtOH owing to the presence of 
PEG, but as TEM images shown in Figure 32 reveal, particle morphologies are nearly identical 
in both cases. This, notably, contradicts DLS evidence discussed above that overall particle size 
changed when PEG was added to SCIOs post-synthesis. However, given PEG‘s hydrophilicity, 
DLS may be more sensitive to changes in particle diameter than TEM.  
 
 
Figure 32. TEM images of FexOy@SiO2 NPs synthesized using the reverse microemulsion method terminated after 
1 hour with A) PEG/EtOH and B) EtOH  
 
Ultimately, although TEM offers insight into core-shell morphology, it was difficult to 
glean evidence of PEG surface functionalization during or after microemulsion synthesis from 
TEM images. Notably, manual quantitative measurements of particles using the current TEM 
instrument are also approximate and a statistical comparison would require a tedious random 
sampling over a large area. The low resolution (~ 0.5 nm) of the TEM instrument is a significant 
limitation of any quantitative investigation. Thus, DLS may be a better characterization method 
to assess and tune PEG functionalization if aggregation limitations can be overcome.  
3.1.1.4  Microemulsion reaction time can tune SCIO particle size  
Simultaneous to investigating the effect of PEG on SCIO particle size and morphology, 
TEM was also used to see if the size of the silica layer could be tuned by varying reaction time. 
This study was motivated by Narita et al. who reported that thickness of the silica layer could be 
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tuned to 2-10 nm by using 1-10 hour reaction times, respectively
34
. To investigate this further, 
TEM images were taken of the PEG/EtOH terminated product of the microemulsion silica 
synthesis after 1, 2, 3, and 5 hours (Figure 33). 
 
Figure 33. TEM images of FexOy@SiO2 NPs synthesized using the reverse microemulsion method terminated after 
1, 2, 3, and 5 hours with PEG/EtOH. To emphasize particle morphologies, a yellow border was drawn to denote 
silica boundaries and a white border was drawn to indicate the FexOy core of selected particles.  
Using the crude TEM measurement protocol, a 1-5 nm layer of silica was evident around SPIO 
cores for all time points, but no consistent patterned increase in size was observed. The most 
monodisperse particles were observed at the 1 hr reaction time, which had consistent 1-3 nm 
thick silica coatings and visibly particulate character (as opposed to being caught in a matrix of 
silica as shown in the 2 hr and 5 hr time points in Figure 33). Polydispersity remained a critical 
issue of the silica coating process for the 2, 3, and 5 hr batches. Often, aggregates and/or various 
sizes of NPs were evident in nearby clusters again; Figure 34 is a representative TEM image of 




Figure 34. TEM image of polydisperse FexOy@SiO2 NPs synthesized using the reverse microemulsion method 
terminated after 3 hours with PEG/EtOH.  
The evident core-shell morphology and thin (1-3 nm) silica coating of the 1 hr batch is the most 
promising synthetic outcome of silica syntheses explored to date for the purpose of building a 
versatile platform for targeted cancer therapy (Figure 35).  
 
Figure 35. TEM images of FexOy@SiO2 NPs synthesized using the reverse microemulsion method terminated after 
1 hour with PEG/EtOH. Images are identical, but shown at different contrast/brightness levels to emphasize silica 
coating (boundary drawn around one NP in yellow on the left image) and iron oxide cores (boundary drawn around 
one NP in white on right image).  
 
One drawback, however, was the observation of large clumps (> 50 nm) of silica in certain 
regions of the TEM grid. Theoretically, collection by a magnet should be sufficient to isolate 
only the FexOy@SiO2 particles, but Narita et al. also propose additional centrifugation steps that 
should be explored to eliminate the excess silica
34
. It is difficult to propose a trend for the nature 
of aggregation taking place at the other time points because TEM is not an ensemble 
measurement like DLS, for example. Notably, however, less aggregation for the shortest time 
point (1 hr) overcomes the size-monodispersity trade-off observed in the Stöber method, which 
favored the particulate nature of larger particles. This is likely due to the role of the surfactant 
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around the SPIOs, which selectively controls how and how much of reagents can interact with 
the SPIO surface. In this regard it is plausible that at longer time points more TEOS may be able 
to get ―inside‖ the micelle formed by the non-ionic surfactant, thereby disrupting the micelle 
structure and facilitating the formation of aggregated and less monodisperse matrices of SPIOs 
embedded in silica seen at 2 hr and 5 hr time points in Figure 33. 
3.1.2 FexOy@PEG NPs 
 
An alternative scaffold-protective layer for the SPIO core bypasses dense polymeric and 
metallic matrices (e.g. silica and gold, respectively) altogether and involves functionalizing the 
SPIO surface with a hydrophilic and biocompatible ligand such as PEG. Terminal hydrophilic 
hydroxyl groups on PEG 1) afford antibiofouling properties that can enhance blood half-life of a 
PEGylated species in vivo and 2) serve as versatile attachment sites for functionalization with 
common chemical functional groups and biomolecules, such as biotin. An early concern with 
PEG functionalization on SPIO surfaces was that it often took place via noncovalent dipole-
dipole interactions that would be unstable in biological environments
45
. However, Lee et al. 
demonstrated that SPIOs coated with a PEG-silane species are indeed stable and have MRI-
contrast agent capability in vivo, which can be attributed in part to the strong silane anchoring 
group that covalently attaches the PEG species to the SPIO surface
45
. 
3.1.2.1  FT-IR and TEM confirm PEGylation of SPIOs in EtOH 
The FT-IR spectrum of the PEGylated product reveals the presence of sp
3 
C-H stretches 
and a fingerprint region with a prominent C-O bend associated with the polymeric backbone of 
the PEG-silane species (Figure 36). Although FT-IR confirms the presence of PEG, it does not 
give an indication of whether or not it is adsorbed to the SPIO surface. Despite the wash and 
collection steps after PEGylation that attempt to get rid of unreacted PEG in solution, ineffective 
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wash steps could allow freely floating PEG to contribute to the IR signal. Therefore, to confirm 
efficacy of these washing steps, a negative control functionalization of SPIOs was performed 
with a PEG-thiol species (MW = 2300). Because thiol (-SH) groups lack covalent affinity to the 
hydroxyl groups on the SPIO surface, no PEGylation was expected occur and, thus, any signal 
from PEG in the IR spectrum of the product post-washing can be attributed to freely floating 
PEG and indicate poor efficacy of washing steps. No PEG signature is seen in the IR spectrum of 
the PEG-thiol functionalization, which is an indirect confirmation that PEG is adsorbed to the 
surface in the PEG-silane functionalization.  
 
Figure 36. FT-IR spectra of Trimethoxy PEG-silane (MW = 1050), Bare FexOy (EMG 304®), FexOy@PEG-thiol 
(MW = 2300), and FexOy@PEG-silane (MW = 1050) NPs. Functionalization with PEG species was performed in 
EtOH ~ 24 hours. Samples were washed/collected in EtOH and left to dry for 5-10 minutes on sample holder before 
IR spectra were obtained. Note presence of C-H stretch and PEG fingerprint vibrations in PEG-silane, but not PEG-
thiol FexOy@ functionalization. 
 
TEM images of SPIO cores with and without PEG also gave additional visual confirmation 
of successful PEGylation (Figure 37). The increased inter-particle distance among PEGylated 







Figure 37. TEM images of A) bare and B) PEGylated SPIO cores. Visually there is an expected increase in inter-
particle distance of the PEGylated product (indicated in selected regions by yellow arrows) as compared to the bare 
SPIO cores, which appear more aggregated.  
 
3.2 MRI Contrast effect of FexOy NPs 
To quantify the MRI contrast capabilities of SPIOs, a protocol for measuring T2 molar 
relaxivity (r2) of SPIOs was first optimized building on previous work (section 3.2.1) and then r2 
values were calculated for surface-modified SPIOs (section 3.2.2) to understand the impact of 
surface chemistry and overall particle size on improving, maintaining, or worsening T2 contrast 
of SPIOs in MR images.   
3.2.1 Different r2 values in H2O vs. Agarose 
T2 relaxivity studies previously performed on SPIOs by Yayla
5
 used phantoms that 
contained tubes of SPIOs suspended in agarose and yielded r2 values ten times greater than r2 
values reported in literature (see Table 2 in Introduction). This discrepancy is likely attributed to 
the fact that it is standard practice to report molar relaxivity values for SPIOs dissolved in water 
instead of agarose. Repeating the T2 relaxivity study outlined by Yayla on bare SPIOs dissolved 






; n = 3) a factor of ten times smaller 
                                                          
[13]
 The standard deviation calculated for n = 3 independent measurements of molar relaxivity may be associated 
with a variety of factors: uncertainty associated with concentration measurements, dilutions, and/or slight variations 
in automated scan parameters for each imaging session. With regard to the latter, efforts were made to alleviate such 
Rana 52 
 









this hypothesis. It is expected that absolute T2 relaxation times should be different in water and 
agarose because agarose - a gel - is a more ―compact‖ environment that will facilitate more spin-
spin dephasing than pure water, resulting in a smaller T2 time for agarose. Because r2 is 
inversely related to T2 according to equation (8), a smaller T2 value should yield a higher r2 
value for agarose, which is indeed what was observed. Interestingly, Parkes et al. reported r2 
values that were independent of agarose or water suspensions of cobalt NPs
46
. Parkes claims this 
indicates there is no further aggregation of particles upon dispersion in agarose. However, it may 
also be possible that aggregation is offsetting the effect of the medium – agarose or water, as 
discussed above – on r2. If the latter is occurring, our results suggest particles are aggregating 
differently in agarose than water since there is a ten-fold difference in molar relaxivity values. 
Specifically, if deviation from literature r2 values is a marker of aggregation, it suggests our 
particles are, in accordance with Parkes‘ implication, aggregating more in agarose than water. 
Whatever the cause of the discrepancy (i.e. suspending medium and/or aggregation), water 
suspensions of SPIOs proved much easier to handle and prepare than the agarose counterparts. 




) is consistent with those reported in the literature. Ji 




for the same Ferrotec EMG 304® SPIO cores 
used in this study. Although this is lower than the value obtained in our study, the discrepancy in 
this case can be attributed to the different methods used to determine [Fe].  




r2 value for bare SPIO cores is higher than the range (50 
– 150 mM-1s-1) of r2 values reported for polymer-coated SPIO contrast agents reported in Table 
2. As discussed in the introduction, size and surface chemistry of polymer coatings can increase 
and/or decrease r2. Ideally, we want to maximize r2 (higher r2, smaller T2, better contrast) so that 
                                                                                                                                                                                           
variations by imaging all sample concentrations in a single scan by using the phantom holder designed by Stephanie 
Huang ‘12 (Figure 22), which can accommodate up to seven 3 mm NMR tubes.     
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it is within or above the range of r2 values in Table 2. In this regard, having a high r2 for bare 
SPIO cores is promising because it offers some room for acceptable loss in contrast due to, for 
example, the physical increase in size that accompanies deposition of a layer or PEG or silica 
onto the SPIO surface.   
3.2.2 r2 values of FexOy@X NPs a function of size and surface chemistry 
In all trials for surface modification of SPIOs with PEG and silica, the r2 value decreased 




). This makes sense: 
regardless of contrast-enhancing surface chemistry interactions that can improve r2 by ―pulling‖ 
more water toward the SPIO core, functionalization procedures nonetheless contribute to an 
overall size increase of the NP that will tend to distance water molecules from the SPIO core, 
lessening the degree of spin-spin relaxation and resulting in lower r2 values (decreased contrast). 
 






FexOy – Ferrotec EMG 304® 470 ± 80 (N = 3) 
@ PEG (MW = 2300) 
(Trimethoxysilane PEG) 
365 
@ PEG (MW = 420) 
(Trimethoxysilane PEG) 
99 
@ PEG (MW = 420) + TEOS 31 
@ APTMS + 2 nm Au NPs   28 
 
Notably data from Table 6 reveal that modification with PEG, a hydrophilic species, shows the 
smallest decrease in r2 from bare SPIOs
[14]









) than bare SPIOs, it is still within or above the range of r2 
values for clinical MRI contrast agents (Table 2). Given the various synthetic alternatives in 
construction of the nanoparticle platform for targeted cancer therapy, this result suggests that 
                                                          
[14] 









), but this may be due to the different [PEG] in each functionalization procedure.   
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PEG may be a favorable component of the scaffold-protective layer around SPIOs not only to 
improve biocompatibility, but to enhance MR image contrast as well. Moreover, LaConte et al. 
report that increasing the PEG coating thickness around 6.6 nm SPIO cores decreases r2, but 
PEG coatings of 5000 > MW > 750 have similar relaxivity values
26
, suggesting at a certain size 
along the functionalization process surface chemistry may play a larger role than an increase in 
size associated with functionalization in affecting r2. This implies that PEG and other biological 
species that associate with water (e.g. Avidin, biotin, Poly-GL) on the surface of the nanovehicle 
may also have the ability to cause a net
[15]
 increase in r2 during later stages of the nanoparticle 
assembly process. Given the low r2 value measured for Au-seeded SPIO cores (synthesized by 
Lisa Jacob ‘12), the surface chemistry of moieties at the surface of the NP will play an especially 
important role in maintaining and/or improving MR contrast.  
Although time did not permit calculation of r2 for Au-coated SPIOs, intensity analysis 
was performed on a MR image of a phantom containing dilute concentrations of 11.2 Au NPs, 
FexOy@Au NPs, and FexOy@(APTMS + 2nm Au NP seeds) (samples synthesized by Lisa Jacob 
‘12). The MR phantom image and corresponding absolute T2 relaxation curves (TE vs. signal 
intensity) are shown in Figure 38. Although absolute T2 relaxivities cannot be used to compare 
the relative efficacy of Au-modified SPIOs to each other or the other surface modified NPs listed 
in Table 6 (since the [Fe] is not taken into account), it is useful to note that FexOy@Au NPs and 
FexOy@(APTMS, 3-Aminopropyltrimethoxysilane, + 2nm Au NP seeds) do produce detectable 
negative contrast in the MR image and have faster T2 relaxation times than water and Au NPs 
according to the relaxivity curves. Au NPs serve as a control because they lack SPIO and do, as 
expected, have a relaxivity curve that matches that of pure water. These preliminary results 
                                                          
[15] 




indicate Au does not visibly inhibit the MR effect of SPIOs and r2 values should be obtained to 




In addition to calculating r2 values for single batches of modified SPIOs reported in Table 
6, r2 values were also calculated for various surface modification reaction conditions to serve as 
another characterization tool to understand the MR contrast effect of coating SPIOs with various 
amounts of silica and/or PEG. In other words, different r2 values for different reaction conditions 
can be indirectly attributed to a change in surface chemistry and/or size of NPs and vice versa.  
 r2 values for SPIOs with 1) varying [PEG]s added during the microemulsion synthesis 
and 2) different reaction times in the silica microemulsion synthesis are shown in Figure 39 and 
Figure 40, respectively. As expected, r2 values increase with an increasing [PEG]. This is 
rationalized by PEG‘s hydrophilic, oxygen rich backbone that can retain water in the proximity 
of the SPIOs for enhanced relaxation. Notably, however, as discussed in section 3.1.1.3, it is not 
clear if the PEG is actually adsorbed to the SPIO surface; changes in r2 could be attributed to 
residual PEG in the solution. Thus, it might be useful to perform a control study analogous to 
that performed for the PEGylation wash and collection steps discussed in section 3.1.2.1 to 
confirm PEGylation on particle surface.  
Figure 38. (A) MR image of a phantom containing tubes with nanopure water (nH2O), Ferrotec@Au (@Au), 
Ferrotec@(APTMS + 2nm Au NP seeds) (@2nmAu), and 11.2 nm Au NPs (Au NPs). Corresponding absolute 
relaxation curves are shown in (B). Note that 11.2 Au NPs have a similar absolute relaxation curve to water while 
samples containing Ferrotec have faster relaxation curves, indicating a MR-contrast effect, which is visible in the MR 




Figure 39. T2 molar relaxivity (r2) values were calculated for Ferrotec samples with different PEG/TEOS ratios 
added during the reverse microemulsion silica synthesis (~24 hour reaction time, terminated with EtOH; TEM 
images of NPs shown in Figure 31). 
 
Despite the fact no significant changes in overall particle size at different time points of 
the silica microemulsion synthesis were detected using TEM (section 3.1.1.4), there is a decrease 
in the r2 of FexOy@SiO2 as reaction time increases (Figure 40).  
 
 
Figure 40. T2 molar relaxivity (r2) values were calculated for Ferrotec samples at different time points in the reverse 
microemulsion synthesis terminated with PEG/nH2O/EtOH solution. 
This is most readily rationalized by an increase in particle size expected at longer time points in 
the microemulsion synthesis, but this was not consistently observed qualitatively in TEM images 
(section 3.1.1.4). Of course, other factors such as aggregation and clustering of NPs (evident, for 





changing r2 values suggest the silica coating is being altered in some way around the SPIO core 
as a function of reaction time. To support and investigate this conclusion further, DLS may be 
able to quantify the corresponding changes in SCIO particle size and/or aggregation that were 
ambiguous in TEM. A particularly notable parallel between TEM and r2 data, however, is the 
rapid decrease in r2 from the 1 hr to 3 hr time points not seen between 3 hr to 5 hr. This supports 
the TEM image observation that SCIOs at 1 hr (1-3 nm silica thickness, largely monodisperse) 
were decidedly distinguishable from those at later time points, all of which appeared to suffer 
from similar degrees of polydispersity and SPIO-silica matrices. That is, less variation in r2 
between the 3 hr and 5 hr than the 1 hr and 3/5 hr time points supports the conclusion from TEM 
that morphology and/or particle size is not changing as significantly between 3-5 hours. With 
regard to producing monodisperse, small, and sensitive MRI-active NPs, therefore, TEM and r2 













4 Conclusions and Suggestions for Future Work 
This study investigated a variety of synthetic routes and characterization methods to build 
a small, monodisperse, surface-modified SPIO core that can serve as a platform for building a 
multifunctional cancer therapeutic-diagnostic nanovehicle. There were three main areas of 
investigation: 
1. FexOy@SiO2 NPs were synthesized using Stöber and reverse microemulsion methods. A 
size-monodispersity trade-off was observed for the Stöber process, which precluded the 
synthesis by this method of small, monodisperse NPs. Small (15-20 nm overall size, 1-3 
nm silica layer thickness), monodisperse FexOy@SiO2 NPs were ultimately synthesized 
with the reverse microemulsion method using a short reaction time (1 hr), but NPs were 
observed using TEM to have small (0-1 nm) inter-particle distances (i.e. heavily 
aggregated). A PEG-silane species was added during and after microemulsion syntheses 
to try and alleviate aggregation, but deposition of PEG could not be confirmed by TEM. 
DLS, FT-IR spectroscopy, and molar relaxivity studies suggest addition of PEG is 
changing the surface chemistry of  FexOy@SiO2 NPs, but these results, especially DLS 
(preliminary) and FT-IR (poor S:N), need to be investigated further to confirm the 
synthesis of FexOy@SiO2@PEG NPs.  
2. FexOy@PEG-Silane NPs were successfully functionalized (confirmed using FT-IR and 
TEM). The next step is to functionalize FexOy@PEG-Silane NPs with biotionylated-PEG 
to take advantage of the affinity between Avidin-biotin proteins, which can serve as the 
―glue‖ for attaching anti-tumor and targeting agents to the NP surface.  
3. T2 molar relaxivity studies were successfully conducted on bare (Ferrotec EMG 304®) 
and surface-modified SPIOs to quantify contrast produced in MR images and to serve as 
another characterization method to monitor changes in surface chemistry and size of the 
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FexOy@PEG and FexOy@SiO2 synthesized NPs. All surface-modified SPIOs had lower r2 




). PEGylated species had the least deviation from 
bare r2 values, likely owing to the favorable hydrophilic surface chemistry that offsets the 
unfavorable addition in size-increase of the particle. A preliminary absolute T2 relaxation 
phantom study also confirmed that FexOy@Au NPs had detectable MR negative contrast. 
The next step is to calculate r2 values for FexOy@Au NPs and surface-modified SPIOs at 





which is the average T2 molar relaxivity of clinical SPIO-based contrast agents
18
. 
The main area for future improvement is in the synthesis of FexOy@SiO2 NPs. Aggregation of 
FexOy@SiO2 NPs was a key issue in all synthetic routes and there was a lack of quantitative 
characterization methods to monitor changes in size and surface chemistry of NPs. 
  There could be several culprits for the observed aggregation in silica syntheses. Roca et 
al. propose the morphology of silica-coated nanostructures is a product of competing chemical 
interactions among silica, the SPIO surface, capping ligands, dipolar forces between SPIOs that 
cause aggregation, and the stability of the protective coating itself
47
. Several studies, which have, 
in turn, guided our research, have already investigated some of these parameters by reporting the 
influence of water/alcohol ratio, the concentration of TEOS, and overall reaction time on the 
final morphology of the FexOy@SiO2 NPs
7,33
. Yet, results from our study suggest aggregation 
persists in all permutations of the silica synthesis. A recent analysis on the role of SPIO capping 
ligands, however, demonstrated that ligand functional groups have a remarkable influence on the 
aggregation of SPIOs encapsulated by silica using the Stöber procedure
47
. Specifically, Roca et 
al. reported that SPIOs coated with tri(ethylene glycol) (TREG) favored the formation of silica 
aggregates while SPIOs coated with dimercaptosuccinic acid (DMSA) showed excellent long-
term, individual particle stability. Carboxylate and thiol moieties on DMSA were hypothesized 
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to prevent SPIO aggregation by affording added stability to DMSA-coated SPIOs in solution. 
Given there is an unknown ―water-soluble dispersant‖ in the commercially-synthesized Ferrotec 
EMG 304® SPIO colloidal suspension, it may be worth investigating in SPIOs with different 
capping ligands to see if/how this affects NP aggregation in silica syntheses.  
 Alternatively, Narita et al. also report that aggregation of core-shell FexOy@SiO2 NPs can 
be prevented by surface modification of the silica-coated product with a silane coupling agent 
containing an imidazolium cationic moiety prior to wash steps
34
. In our study, FexOy@SiO2 NP 
products were collected and washed simply using EtOH. This, however, could be facilitating the 
sol-gel reaction between particles, contributing to additional aggregation. Further investigations 
with PEG-silane and/or amine- or thiol-based silane coupling agents that can be added directly to 
the microemulsion synthesis before wash steps may help alleviate FexOy@SiO2 NP aggregation. 
Moreover, the Narita et al. study also suggests that surface-modification post-synthesis may not 
be effective because the silica-coated NPs are already too aggregated after wash steps. 
 Finally, additional characterization methods should be investigated. Although DLS data 
on bare SPIOs are limited by inter-particle aggregation, DLS has been successfully performed on 
monodisperse suspensions of PEGylated and silica-coated SPIOs to obtain hydrodynamic size 
information
47
. The first step to improve DLS measurements will be to limit aggregation in the 
silica synthesis. DLS may also serve as a useful tool to monitor aggregation of NPs by measuring 
a quantity called the polydispersity index (PDI). Moreover, TEM analysis is not particularly 
relevant for assessing solution-based chemistry, which is another reason to pursue and optimize 
DLS measurements. Another popular characterization method of SPIOs in literature is to obtain 
magnetic hysteresis curves of samples
7,47
 like those shown in Figure 11. Measurements of 
magnetic susceptibility can be obtained in this way using a SQUID (superconducting quantum 
interference device) magnetometer. Changes in B vs. M curves can then be correlated with 
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changes in size and/or surface chemistry of NPs. Moreover, these data can be used in 
conjunction with relaxivity data since the magnetic moment μ can be back-calculated from the B 
vs. M curve
48
 and R2      according to equation (9). 
 The project offers many avenues to continue exploring an improving. Once small, 
monodisperse, and de-aggregated FexOy@SiO2 NPs are optimally synthesized, either a thin layer 
of gold can be deposited onto the silica
7
 to take advantage of previously well-studied ligand-gold 
interactions in the Flynn lab
29
 or functional moieties can be directly attached to the hydroxyl-rich 
silica surface by, for example, introducing a biotionylated-PEG species to serve as an Avidin-
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